Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07725484) titled 'Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients' on July 21.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: Shanghai Zhongshan Hospital

Condition: Heart Failure Due to Coronary Artery Disease

Intervention: Drug: Alpha-Lipoic Acid (ALA)

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: August 1, 2026

Target Sample Size: 1526

Countries of Recruitment: China

To know more, visit https://clinicaltrials...